The Journal of Urology
Volume 180, Issue 5 , Pages 1912-1917 , November 2008

Outcomes Following Partial Nephrectomy by Tumor Size

  • Paul L. Crispen

      Affiliations

    • Department of Urology, Mayo Clinic, Rochester, Minnesota
    • ,
  • Stephen A. Boorjian

      Affiliations

    • Department of Urology, Mayo Clinic, Rochester, Minnesota
    • ,
  • Christine M. Lohse

      Affiliations

    • Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota
    • ,
  • Thomas S. Sebo

      Affiliations

    • Department of Pathology, Mayo Clinic, Rochester, Minnesota
    • ,
  • John C. Cheville

      Affiliations

    • Department of Pathology, Mayo Clinic, Rochester, Minnesota
    • ,
  • Michael L. Blute

      Affiliations

    • Department of Urology, Mayo Clinic, Rochester, Minnesota
    • ,
  • Bradley C. Leibovich

      Affiliations

    • Department of Urology, Mayo Clinic, Rochester, Minnesota
    • Corresponding Author InformationCorrespondence: Department of Urology, Mayo Clinic, Rochester, Minnesota 55905 (telephone: 507-774-3722; FAX: 507-284-4951)

Received 29 February 2008

References 

  1. Uzzo RG, Novick AC. Nephron sparing surgery for renal tumors: indications, techniques and outcomes. J Urol. 2001;166:6
  2. Lucas SM, Stern JM, Adibi M, Zeltser IS, Cadeddu JA, Raj GV. Renal function outcomes in patients treated for renal masses smaller than 4 cm by ablative and extirpative techniques. J Urol. 2008;179:75
  3. Hafron J, Kaouk JH. Ablative techniques for the management of kidney cancer. Nat Clin Pract Urol. 2007;4:261
  4. Crispen PL, Uzzo RG. The natural history of untreated renal masses. BJU Int. 2007;99:1203
  5. Kunkle DA, Egleston BL, Uzzo RG. Excise, ablate or observe: the small renal mass dilemma: a meta-analysis and review. J Urol. 2008;179:1227
  6. Stern JM, Svatek R, Park S, Hermann M, Lotan Y, Sagalowsky AI, et al. Intermediate comparison of partial nephrectomy and radiofrequency ablation for clinical T1a renal tumours. BJU Int. 2007;100:287
  7. Frank I, Blute ML, Cheville JC, Lohse CM, Weaver AL, Zincke H. Solid renal tumors: an analysis of pathological features related to tumor size. J Urol. 2003;170:2217
  8. Thompson RH, Boorjian SA, Lohse CM, Leibovich BC, Kwon ED, Cheville JC, et al. Radical nephrectomy for pT1a renal masses may be associated with decreased overall survival compared with partial nephrectomy. J Urol. 2008;179:468
  9. Lane BR, Samplaski MK, Herts BR, Zhou M, Novick AC, Campbell SC. Renal mass biopsy: a renaissance?. J Urol. 2008;179:20
  10. Chawla SN, Crispen PL, Hanlon AL, Greenberg RE, Chen DY, Uzzo RG. The natural history of observed enhancing renal masses: meta-analysis and review of the world literature. J Urol. 2006;175:425
  11. Hafez KS, Fergany AF, Novick AC. Nephron sparing surgery for localized renal cell carcinoma: impact of tumor size on patient survival, tumor recurrence and TNM staging. J Urol. 1999;162:1930
  12. Fergany AF, Hafez KS, Novick AC. Long-term results of nephron sparing surgery for localized renal cell carcinoma: 10-year followup. J Urol. 2000;163:442
  13. Lane BR, Babineau D, Kattan MW, Novick AC, Gill IS, Zhou M, et al. A preoperative prognostic nomogram for solid enhancing renal tumors 7 cm or less amenable to partial nephrectomy. J Urol. 2007;178:429
  14. Kunkle DA, Crispen PL, Chen DY, Greenberg RE, Uzzo RG. Enhancing renal masses with zero net growth during active surveillance. J Urol. 2007;177:849
  15. Hsu RM, Chan DY, Siegelman SS. Small renal cell carcinomas: correlation of size with tumor stage, nuclear grade, and histologic subtype. AJR Am J Roentgenol. 2004;182:551
  16. Roberts WW, Bhayani SB, Allaf ME, Chan TY, Kavoussi LR, Jarrett TW. Pathological stage does not alter the prognosis for renal lesions determined to be stage T1 by computerized tomography. J Urol. 2005;173:713
  17. Herr HW, Lee CT, Sharma S, Hilton S. Radiographic versus pathologic size of renal tumors: implications for partial nephrectomy. Urology. 2001;58:157
  18. Kanofsky JA, Phillips CK, Stifelman MD, Taneja SS. Impact of discordant radiologic and pathologic tumor size on renal cancer staging. Urology. 2006;68:728
  19. Remzi M, Katzenbeisser D, Waldert M, Klingler HC, Susani M, Memarsadeghi M, et al. Renal tumour size measured radiologically before surgery is an unreliable variable for predicting histopathological features: benign tumours are not necessarily small. BJU Int. 2007;99:1002
  20. Yaycioglu O, Rutman MP, Balasubramaniam M, Peters KM, Gonzalez JA. Clinical and pathologic tumor size in renal cell carcinoma; difference, correlation, and analysis of the influencing factors. Urology. 2002;60:33

 Study received institutional review board approval.

 For another article on a related topic see page 2196.

PII: S0022-5347(08)01850-8

doi: 10.1016/j.juro.2008.07.047

The Journal of Urology
Volume 180, Issue 5 , Pages 1912-1917 , November 2008

Article Tools

* Image Usage & Resolution